Solesence, Inc. (SLSN) 股票分析
防御性消费Solesence, Inc.
$1.28
+$0.03 (+2.81%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Solesence, Inc. operates as a science-driven entity that provides engineered materials, formulation development, and commercial manufacturing services within the United States, specifically focusing on the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. The company functions within the Consumer Defensive sector, specifically under the Household & Personal Products industry, which typically implies stable demand patterns driven by essential consumer goods consumption regardless of broader economic cycles. Currently, Solesence, Inc. holds a market capitalization of $92.53M, generates annual revenue of $62.06M, and maintains a workforce of 115 employees. These valuation and revenue figures indicate that the company occupies a small-cap position within its sector, suggesting a niche market presence rather than broad-scale dominance, yet it maintains sufficient scale to support specialized manufacturing operations for its engineered ingredient portfolio.
财务健康
Solesence, Inc. reported total revenue of $62.06M for the trailing twelve months, with net income of $1.79M and an EBITDA of $2.47M. The significant gap between revenue of $62.06M and net income of $1.79M reveals a cost structure characterized by substantial operating expenses, which compresses the final profit despite a positive EBITDA. The company's free cash flow stands at -$11,546,625, indicating a current lack of financial flexibility where operating cash outflows exceed cash generation, potentially necessitating external funding or asset monetization. Profitability is further detailed by three key margins: a gross margin of 25.9%, an operating margin of 1.5%, and a profit margin of 2.9%, where the low operating margin relative to gross margin suggests high overhead costs or significant SG&A expenses eroding gross profits. Regarding liquidity and leverage, the company holds $1.29M in cash against $24.32M in debt, resulting in a debt-to-equity ratio of 137.91% which characterizes the balance sheet as highly leveraged rather than conservative. Short-term liquidity is supported by a current ratio of 2.07, indicating that current assets are more than double current liabilities, providing a buffer for immediate obligations. Return metrics show a return on equity of 11.0% and a return on assets of 2.0%, where the disparity highlights that equity holders are being rewarded more effectively than asset holders, a phenomenon often seen in capital-intensive or highly leveraged structures.
估值评估
The company trades with a trailing P/E ratio of 65.50, while the forward P/E is not available, a discrepancy that implies analysts lack sufficient data to project a lower multiple based on anticipated future earnings growth. The price-to-book ratio is 5.24, suggesting the market prices the company at a significant premium over its tangible book value, reflecting high expectations for future intangible growth or brand value despite current earnings constraints. Alternative valuation metrics include a price-to-sales ratio of 1.49 and an EV/EBITDA of 46.80, which collectively suggest the market is willing to pay a high multiple for revenue and earnings, potentially compensating for the lack of forward P/E visibility. The stock's recent price volatility is bounded by a 52-week high of $16.56 and a 52-week low of $0.78, meaning the current trading price sits significantly below the 52-week high, reflecting the severe drawdown from recent peak valuations. The beta value of 1.17 indicates that the stock exhibits higher price volatility relative to the broader market, moving approximately 17% more aggressively than the index in response to market fluctuations.
Growth & Income
Solesence, Inc. experienced a revenue growth rate of -0.7% year-over-year, while earnings growth is not applicable due to the absence of comparable prior period data or specific reporting standards, indicating that current earnings are not growing faster than revenue but rather reflecting a contraction in top-line sales. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which implies that all available earnings are retained within the business to fund operations, repay debt, or invest in future growth initiatives rather than being distributed to shareholders. Since the company is a non-dividend payer, the growth profile is entirely dependent on organic revenue recovery or expansion, as indicated by the recent negative revenue growth of -0.7%. Overall, the growth and income profile is characterized by a lack of current income generation via dividends and a recent contraction in revenue, requiring the company to rely on operational efficiency and market share gains to restore positive growth trajectories.
同行比较
Solesence, Inc. (SLSN) 在家庭与个人护理产品行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Solesence, Inc. | SLSN | $90.41M | 128.0 |
| The Procter & Gamble Company | PG | $336.34B | 21.1 |
| Unilever PLC | UL | $123.97B | 19.0 |
| Colgate-Palmolive Company | CL | $71.90B | 34.8 |
家庭与个人护理产品行业平均市盈率为29.9倍。Solesence, Inc.的市盈率为128.0。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关家庭与个人护理产品股票
The Procter & Gamble Company
$336.34B
ULUnilever PLC
$123.97B
CLColgate-Palmolive Company
$71.90B
KVUEKenvue Inc.
$33.58B
KMBKimberly-Clark Corporation
$32.79B
ELThe Estée Lauder Companies Inc.
$31.33B
防御性消费热门股票
Walmart Inc.
$945.12B
COST.TOCostco Wholesale Corporation
$587.62B
COSTCostco Wholesale Corporation
$444.95B
KOThe Coca-Cola Company
$346.18B
PMPhilip Morris International Inc.
$294.55B
关于Solesence, Inc.
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
公司简介以英文显示。
访问官网 →